A randomized study comparing interferon (IFN alpha) plus low-dose cytarabine and interferon plus hydroxyurea (HU) in early chronic-phase chronic myeloid leukemia (CML).

Kühr T, Burgstaller S, Apfelbeck U, Linkesch W, Seewann H, Fridrik M, Michlmayr G, Krieger O, Lutz D, Lin W, Pont J, Köck L, Abbrederis K, Baldinger C, Buder R, Geissler D, Hausmaninger H, Lang A, Zabernigg A, Duba C, Hilbe W, Eisterer W, et al. Leuk Res. 2003 May,27(5):405-11.

Prognostic significance of CD20 expression in classical Hodgkin lymphoma: a clinicopathological study of 119 cases.

Tzankov A, Krugmann J, Fend F, Fischhofer M, Greil R, Dirnhofer S. Clin Cancer Res. 2003 Apr,9(4):1381-6.

Longer failure-free survival interval of Epstein-Barr virus-associated classical Hodgkin’s lymphoma: a single-institution study.

Krugmann J, Tzankov A, Gschwendtner A, Fischhofer M, Greil R, Fend F, Dirnhofer S. Mod Pathol. 2003 Jun,16(6):566-73.

Tracking death dealing by Fas and TRAIL in lymphatic neoplastic disorders: pathways, targets and therapeutic tools.

Greil R, Anether G, Johrer K, Tinhofer I. J Leukoc Biol. 2003 Sep,74(3):311-30.

Tuning the rheostat of the myelopoietic system via Fas and TRAIL.

Greil R, Anether G, Johrer K, Tinhofer I. Crit Rev Immunol. 2003,23(4):301-22.

Treatment of advanced Hodgkin’s disease with COPP/ABV/IMEP versus COPP/ABVD and consolidating radiotherapy: final results of the German Hodgkin’s Lymphoma Study Group HD6 trial.

Sieber M, Tesch H, Pfistner B, Rueffer U, Paulus U, Munker R, Hermann R, Doelken G, Koch P, Oertel J, Roller S, Worst P, Bischof H, Glunz A, Greil R, von Kalle K, Schalk KP, Hasenclever D, Brosteanu O, Duehmke E, Georgii A, Engert A, et al. Ann Oncol. 2004 Feb,15(2):276-82.

Transendothelial migration of myeloma cells is increased by tumor necrosis factor (TNF)-alpha via TNF receptor 2 and autocrine up-regulation of MCP-1.

Jöhrer K, Janke K, Krugmann J, Fiegl M, Greil R. Clin Cancer Res. 2004 Mar 15,10(6):1901-10.

Unfavourable prognosis of patients with trisomy 18q21 detected by fluorescence in situ hybridisation in t(11,18) negative, surgically resected gastrointestinal B cell lymphomas.

Krugmann J, Tzankov A, Dirnhofer S, Fend F, Greil R, Siebert R, Erdel M. J Clin Pathol. 2004 Apr,57(4):360-4.

Quality of life of patients with chronic lymphocytic leukemia: results of a longitudinal investigation over 1 yr.

Holzner B, Kemmler G, Kopp M, Nguyen-Van-Tam D, Sperner-Unterweger B, Greil R. Eur J Haematol. 2004 Jun,72(6):381-9.

Normative data for functional assessment of cancer therapy–general scale and its use for the interpretation of quality of life scores in cancer survivors.

Holzner B, Kemmler G, Cella D, De Paoli C, Meraner V, Kopp M, Greil R, Fleischhacker WW, Sperner-Unterweger B. Acta Oncol. 2004,43(2):153-60.